JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, published by Springer Heidelberg, is a pivotal resource in the fields of Analytical Chemistry, Biochemistry, and Clinical Biochemistry. With an ISSN of 0933-4173 and an E-ISSN of 1789-0993, this journal serves as an essential platform for the dissemination of innovative research on planar chromatography techniques, specifically modern thin-layer chromatography (TLC). With its upcoming coverage extending to 2024 and a third quartile ranking (Q3) across major scientific categories in 2023, it addresses the critical advancements and applications in analytical methods. Although it does not offer open access, the journal's rigorous peer-review process ensures high-quality findings that contribute to the progression of these vital scientific disciplines. The journal is located in Heidelberg, Germany, and continues to be a beacon for researchers, professionals, and students who seek to enhance their knowledge and practice in chromatographic techniques.

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

Drug Testing and Analysis is a leading scholarly journal published by WILEY, dedicated to advancing the field of drug testing and analytical methods. With ISSN 1942-7603 and E-ISSN 1942-7611, this journal provides a platform for the latest research in Analytical Chemistry, Pharmaceutical Science, and Environmental Chemistry, holding a prestigious reputation reflected in its Q1 and Q2 rankings across various categories in 2023. The journal promotes high-impact studies that explore innovative methodologies, with a specific focus on pharmacological and toxicological analyses, making it an essential resource for researchers, professionals, and students concerned with drug efficacy, safety, and environmental impact. With a strong commitment to quality and relevance, Drug Testing and Analysis remains at the forefront of contemporary scientific inquiry, contributing significantly to both academic and practical advancements in the industry.

CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.

Biomedical Chromatography is a prestigious journal published by Wiley, focusing on the vital intersections of analytical chemistry, biochemistry, and clinical studies. With an ISSN of 0269-3879 and E-ISSN of 1099-0801, it has served the research community since its inception in 1986. The journal provides a platform for innovative research in areas such as drug discovery and pharmacology, achieving a commendable placement in Q3 across multiple categories in the 2023 metrics, including Analytical Chemistry and Biochemistry. Although it currently does not offer open access, it plays a crucial role in disseminating scientific developments and methodologies that contribute to advancements in health, safety, and pharmaceuticals. Researchers, professionals, and students can anticipate high-quality, peer-reviewed articles that drive forward the collective knowledge in biomedical applications. Located in the United Kingdom at 111 River St, Hoboken, NJ, the journal continues to attract contributions from global thought leaders in the field.

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

ACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.

The Journal of Analytical Methods in Chemistry, published by HINDAWI LTD, stands as a premier platform dedicated to the dissemination of research in the vibrant field of analytical chemistry. With an ISSN of 2090-8865 and an E-ISSN of 2090-8873, this Open Access journal has been committed to providing unrestricted access to quality research since 1978, thereby fostering greater collaboration and innovation among researchers, professionals, and students globally. The journal showcases rigorous research insights spanning diverse categories, earning impressive Scopus rankings including Q2 in Chemical Engineering and Q3 in Analytical Chemistry for 2023, positioning itself effectively among respected peers. Its interdisciplinary approach also covers significant contributions in the realms of instrumentation and computer science applications, thus addressing contemporary challenges and advancements in analytical methodologies. By bridging theoretical underpinnings with practical applications, the Journal of Analytical Methods in Chemistry aims to catalyze knowledge exchange while enhancing the global discourse in analytical science.

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.